 Two of these drugs, nevirapine and efavirenz, are cornerstones of first line HAART while delavirdine is hardly used nowadays.The structure of these three drugs show the wide array of rings, substituents, and bonds that allow activity against HIV-1 RT.This diversity demonstrates why so many non-nucleosides have been synthesised but doesn't explain why only three drugs have reached the market.